logo
Select company
Select metric
1.04%EBIT Margin
VS
Market
38
Sector
69
Industry
83
History
100
$ 1.29Close
$ 1.06 - $ 2.55 52-Week Range
Ticker Information

Ticker

HRTX

Company Name

HERON THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

HERON THERAPEUTICS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

HRTX - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ 1.55M1.04%$ 149.69M
3/31/2025$ -5.3M-3.57%$ 148.52M
12/31/2024$ -11.1M-7.69%$ 144.28M
9/30/2024$ -27.46M-19.94%$ 137.74M
6/30/2024$ -47.62M-34.92%$ 136.36M
3/31/2024$ -80.45M-60.9%$ 132.1M
12/31/2023$ -110.06M-86.63%$ 127.04M
9/30/2023$ -118.87M-96.77%$ 122.84M
6/30/2023$ -135.77M-115.09%$ 117.96M
3/31/2023$ -150.07M-131.84%$ 113.83M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • HERON THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT % stands at -221.79%.
  • Over the past 5 years, HERON THERAPEUTICS INC's average EBIT % has been -149.85%.
  • The median EBIT % for HERON THERAPEUTICS INC during this period was -150.06%
  • HERON THERAPEUTICS INC reached its highest EBIT % over the past 5 years at 1.04%.
  • The lowest EBIT % recorded by HERON THERAPEUTICS INC in the same timeframe -284.07%

HERON THERAPEUTICS INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
GLUE : MONTE ROSA THERAPEUTICS INC 15.97%CHRS : COHERUS ONCOLOGY INC 136.5%TRDA : ENTRADA THERAPEUTICS INC -96.77%MGNX : MACROGENICS INC -20.84%VNDA : VANDA PHARMACEUTICALS INC -41.77%AGEN : AGENUS INC -81.58%IGMS : IGM BIOSCIENCES INC -36.8%OSUR : ORASURE TECHNOLOGIES INC -34.69%ARCT : ARCTURUS THERAPEUTICS HOLDINGS INC -61.89%ALEC : ALECTOR INC -142.04%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for HERON THERAPEUTICS INC is calculated as follows: EBIT [ $ -228.7M ] / Revenues [ $ 103.12M ]
(=) EBIT % [ -221.79% ]

HRTX - EBIT Margin, Last 5 years

-284.07%

Minimum

Jun 30, 2021

1.04%

Maximum

Jun 30, 2025

-149.85%

Average

-150.06%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.54% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.54%
median9.01%
std23.96%